← 產業報告目錄
Antibody Discovery Market Size, Share & Trends Analysis Report By Antibody Discovery Step (Hit Generation, Lead Selection, Lead Optimization), By Antibody Discovery Method (Hybridoma-based Methods, Phage Display Library-based Methods, Transgenic Animal-based Methods, Yeast Display-based Methods, Single Cell-based Methods, Other Methods), By Nature of Antibody, By Therapeutic Area, By Type of Antibody, By End-User, Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-09頁數 180報告編號 INSIGHTACE-d2fa951966
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Antibody Discovery Market stood at USD 2.07 billion in 2024, and is projected to reach USD 5.42 billion by 2034, recording a CAGR of 10.2% from 2025 through 2034.
Antibody Discovery encompasses key industry insights & findings from the report:
The proliferation of infectious diseases and the development of effective therapeutic antibodies against them are driving forces behind this industry. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Growth is supported by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Antibody Discovery Market Snapshot
Chapter 4. Global Antibody Discovery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Antibody Discovery Step Estimates & Trend Analysis
5.1. By Antibody Discovery Step, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Antibody Discovery Step:
5.2.1. Hit Generation
5.2.2. Lead Selection
5.2.3. Lead Optimization
Chapter 6. Market Segmentation 2: By Antibody Discovery Method Estimates & Trend Analysis
6.1. By Antibody Discovery Method & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Antibody Discovery Method:
6.2.1. Hybridoma-based Methods
6.2.2. Phage Display Library-based Methods
6.2.3. Transgenic Animal-based Methods
6.2.4. Yeast Display-based Methods
6.2.5. Single Cell-based Methods
6.2.6. Other Methods
Chapter 7. Market Segmentation 3: By Nature of Antibody Estimates & Trend Analysis
7.1. By Nature of Antibody & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Nature of Antibody:
7.2.1. Human Antibodies
7.2.2. Humanized Antibodies
7.2.3. Chimeric Antibodies
7.2.4. Murine Antibodies
Chapter 8. Market Segmentation 4: By Therapeutic Area Estimates & Trend Analysis
8.1. By Therapeutic Area & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic Area:
8.2.1. Hybridoma-based Methods
8.2.2. Phage Display Library-based Methods
8.2.3. Transgenic Animal-based Methods
8.2.4. Yeast Display-based Methods
8.2.5. Single Cell-based Methods
8.2.6. Other Methods
Chapter 9. Market Segmentation 5: By Type of Antibody Estimates & Trend Analysis
9.1. By Type of Antibody & Market Share, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type of Antibody:
9.2.1. Monoclonal Antibodies
9.2.2. Bispecific Antibodies
9.2.3. Antibody Drug Conjugates
9.2.4. Immunoconjugates
9.2.5. Other Antibodies
Chapter 10. Market Segmentation 6: By End User Estimates & Trend Analysis
10.1. By End User & Market Share, 2024 & 2034
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
10.2.1. In-house Players
10.2.2. Contract Research Organizations
Chapter 11. Antibody Discovery Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Antibody Discovery Step, 2021-2034
11.1.2. North America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Antibody Discovery Method, 2021-2034
11.1.3. North America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Nature of Antibody, 2021-2034
11.1.4. North America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
11.1.5. North America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Type of Antibody, 2021-2034
11.1.6. America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
11.1.7. North America Antibody Discovery Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
11.2. Europe
11.2.1. Europe Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Step, 2021-2034
11.2.2. Europe Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Method, 2021-2034
11.2.3. Europe Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Nature of Antibody, 2021-2034
11.2.4. Europe Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
11.2.5. Europe Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Type of Antibody, 2021-2034
11.2.6. Europe Antibody Discovery Market revenue (US$ Million) By End User, 2021-2034
11.2.7. Europe Antibody Discovery Market revenue (US$ Million) by country, 2021-2034
11.3. Asia Pacific
11.3.1. Asia Pacific Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Step, 2021-2034
11.3.2. Asia Pacific Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Method, 2021-2034
11.3.3. Asia Pacific Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Nature of Antibody, 2021-2034
11.3.4. Asia Pacific Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
11.3.5. Asia Pacific Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Type of Antibody, 2021-2034
11.3.6. Asia Pacific Antibody Discovery Market revenue (US$ Million) By End User, 2021-2034
11.3.7. Asia Pacific Antibody Discovery Market revenue (US$ Million) by country, 2021-2034
11.4. Latin America
11.4.1. Latin America Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Step, (US$ Million) 2021-2034
11.4.2. Latin America Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Method, (US$ Million) 2021-2034
11.4.3. Latin America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Nature of Antibody, 2021-2034
11.4.4. Latin America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
11.4.5. Latin America Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Type of Antibody, 2021-2034
11.4.6. Latin America Antibody Discovery Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
11.4.7. Latin America Antibody Discovery Market revenue (US$ Million) by country, 2021-2034
11.5. Middle East & Africa
11.5.1. Middle East & Africa Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Step, (US$ Million) 2021-2034
11.5.2. Middle East & Africa Antibody Discovery Market revenue (US$ Million) By Antibody Discovery Method, (US$ Million) 2021-2034
11.5.3. Middle East & Africa Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Nature of Antibody, 2021-2034
11.5.4. Middle East & Africa Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
11.5.5. Middle East & Africa Antibody Discovery Market revenue (US$ Million) estimates and forecasts By Type of Antibody, 2021-2034
11.5.6. Middle East & Africa Antibody Discovery Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
11.5.7. Middle East & Africa Antibody Discovery Market revenue (US$ Million) by country, 2021-2034
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Ablexis
12.2.2. Abwiz Bio
12.2.3. Abzena
12.2.4. Aragen Life Sciences
12.2.5. BIOTEM
12.2.6. ChemPartner
12.2.7. Creative Biolabs
12.2.8. DetaiBio
12.2.9. FairJourney Biologics
12.2.10. Fusion Antibodies
12.2.11. Genmab
12.2.12. Harbour BioMed
12.2.13. Immunome
12.2.14. ImmunoPrecise Antibodies
12.2.15. Integral Molecular
12.2.16. Isogenica
12.2.17. ProteoGenix
12.2.18. Syd Labs
12.2.19. Viva Biotech
12.2.20. WuXi Biologics
12.2.21. Others Market Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們